U.S. markets closed

Marker Therapeutics, Inc. (MRKR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.6500-0.0500 (-2.94%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
679.979
-
-
-
-
Operating Expense
24,698
-
-
-
-
Operating Income
-24,018
-
-
-
-
Net Non Operating Interest Income Expense
586.949
-
-
-
-
Other Income Expense
65
-
-
-
-
Pretax Income
-23,366
-
-
-
-
Net Income Common Stockholders
-23,366
-
-
-
-
Diluted NI Available to Com Stockholders
-23,366
-
-
-
-
Basic EPS
-
0
-0.0078
-0.0012
0
Diluted EPS
-
0
-0.0078
-0.0012
0
Basic Average Shares
-
45,588
19,092
9,453
6,890
Diluted Average Shares
-
45,588
19,092
9,453
7,421
Total Operating Income as Reported
-24,018
-
-
-
-
Total Expenses
24,698
-
-
-
-
Net Income from Continuing & Discontinued Operation
-23,366
-
-
-
-
Normalized Income
-23,431
-
-
-
-
Interest Income
586.949
-
-
-
-
Net Interest Income
586.949
-
-
-
-
EBIT
-24,018
-
-
-
-
EBITDA
-23,639
-
-
-
-
Reconciled Depreciation
379.193
-
-
-
-
Net Income from Continuing Operation Net Minority Interest
-23,366
-
-
-
-
Total Unusual Items Excluding Goodwill
65
-
-
-
-
Total Unusual Items
65
-
-
-
-
Normalized EBITDA
-23,704
-
-
-
-
Tax Rate for Calcs
0
-
-
-
-
Tax Effect of Unusual Items
0
-
-
-
-